Loading…
Increased Levels of PPARβ/δ and Cyclin D1 in Flat Dysplastic ACF and Adenomas in ApcMin/+ Mice
Background: In Apc Min/+ (Min; multiple intestinal neoplasia) mice two separate populations of aberrant crypt foci (ACF) develop in the colon after azoxymethane (AOM) exposure. ACF Min , with a flat appearance, severe dysplasia and increased β-catenin expression, are related to adenoma development,...
Saved in:
Published in: | Anticancer research 2005-11, Vol.25 (6B), p.3781 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: In Apc Min/+ (Min; multiple intestinal neoplasia) mice two separate populations of aberrant crypt foci (ACF) develop in the colon after
azoxymethane (AOM) exposure. ACF Min , with a flat appearance, severe dysplasia and increased β-catenin expression, are related to adenoma development, whereas
classic ACF, with elevated structure, hyperplasia and normal β-catenin level, are probably not. Materials and Methods: The
expressions of peroxisome proliferator-activated receptors (PPARs) β/δ cyclin D1 and β-catenin in ACF, adenoma and normal
tissue from AOM-treated Apc Min/+ mice and a familial adenomatous polyposis (FAP) patient colon tumour were assessed by immunohistochemistry and immunoblotting.
Results: The flat ACF (ACF Min ) displayed increased cytoplasmic levels of β-catenin, and increased levels of cyclin D1 and PPARβ/δ. In contrast, the expression
in classic ACF resembled normal mucosa. Adenomas from Apc Min/+ mice, as well as a FAP patient colon tumour, displayed increased nuclear and cytoplasmic levels of β-catenin, and the same
expression patterns of cyclin D1 and PPARβ/δ as those found in flat ACF. Conclusion: In addition to activation of the Wnt
signalling pathway in both flat ACF and in adenomas in Apc Min/+ mice, the increased expression of PPARβ/δ in these lesions could be a target for pro-inflammatory signals important for growth
and reduced apoptosis. |
---|---|
ISSN: | 0250-7005 1791-7530 |